A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy
Clinical trial NCT06635772 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06635772
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.